Société Nanoantibiotics Inc Other OTC
Actions
US63009U1025
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 11/04/16 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 01/10/18 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/11/21 |
Penelope Markham
PRN | Corporate Officer/Principal | 58 | 01/11/18 |
Sarah Hoit
PRN | Corporate Officer/Principal | 57 | 01/02/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 16/06/20 |
Richard Berman
BRD | Director/Board Member | 81 | 24/06/19 |
Jim Lang
CHM | Chairman | 59 | 01/01/16 |
Director/Board Member | 65 | 16/06/20 | |
Sigmund Rogich
BRD | Director/Board Member | 80 | 16/06/20 |
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 11/04/16 |
Michael Sherman
BRD | Director/Board Member | 65 | 25/10/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 54 947 476 | 31 167 893 ( 56,72 %) | 22 880 ( 0,0416 %) | 56,72 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |
- Bourse
- Actions
- Action BIVI
- Action
- Société Nanoantibiotics Inc